Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease | MicrobiomeTrials← Back to trialsNCT07888023
Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11Est. Completion: 2027-11
Enrollment target: 210 participants Other microbiome trials you might be interested in
Uveitis
Background:
\- Uveitis is a general term describing a group of inflammatory diseases of the eye. The causes of uveitis …
Bethesda, United StatesCompleted Jun 29, 2022
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026